{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:34:30Z","timestamp":1792290870336,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-2959-2","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T19:58:21Z","timestamp":1516651101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaoqin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaomai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-7662","authenticated-orcid":false,"given":"Lingling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"issue":"11","key":"2959_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","volume":"8","author":"HR Dalton","year":"2008","unstructured":"Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698\u2013709.","journal-title":"Lancet Infect Dis"},{"issue":"9744","key":"2959_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","volume":"376","author":"FC Zhu","year":"2010","unstructured":"Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376(9744):895\u2013902.","journal-title":"Lancet"},{"issue":"2","key":"2959_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/00365548.2014.968612","volume":"47","author":"F Bazerbachi","year":"2015","unstructured":"Bazerbachi F, Haffar S. Acute fulminant vs. acute-on-chronic liver failure in hepatitis E: diagnostic implications. Infect Dis (Lond). 2015;47(2):112.","journal-title":"Infect Dis (Lond)"},{"issue":"2","key":"2959_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jceh.2013.05.003","volume":"3","author":"N Kamar","year":"2013","unstructured":"Kamar N, Izopet J, Dalton HR. Chronic hepatitis e virus infection and treatment. J Clin Exp Hepatol. 2013;3(2):134\u201340.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"2959_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneurol.2015.234","volume":"12","author":"HR Dalton","year":"2016","unstructured":"Dalton HR, Kamar N, van Eijk JJ, Mclean BN, Cintas P, Bendall RP, Jacobs BC. Hepatitis E virus and neurological injury. Nat Rev Neurol. 2016;12(2):77\u201385.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2959_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5501\/wjv.v4.i4.343","volume":"4","author":"GY Lee","year":"2015","unstructured":"Lee GY, Poovorawan K, Intharasongkroh D, Sa-Nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y. Hepatitis E virus infection: epidemiology and treatment implications. World J Virol. 2015;4(4):343\u201355.","journal-title":"World J Virol"},{"issue":"2","key":"2959_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3201\/eid1702.100856","volume":"17","author":"N Kamar","year":"2011","unstructured":"Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011;17(2):173\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"2959_CR8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1665-2681(19)31434-6","volume":"11","author":"MC Cheung","year":"2012","unstructured":"Cheung MC, Maguire J, Carey I, Wendon J, Agarwal K. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol. 2012;11(5):618\u201322.","journal-title":"Ann Hepatol"},{"issue":"4","key":"2959_CR9","first-page":"365","volume":"43","author":"K Mandal","year":"2006","unstructured":"Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 2006;43(4):365\u20136.","journal-title":"Indian Pediatr"},{"issue":"1","key":"2959_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/gow001","volume":"4","author":"F Bazerbachi","year":"2016","unstructured":"Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep (Oxf). 2016;4(1):1\u201315.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"24","key":"2959_CR11","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366(24):2294\u2013304.","journal-title":"N Engl J Med"},{"issue":"5","key":"2959_CR12","first-page":"216","volume":"24","author":"P Kamani","year":"2005","unstructured":"Kamani P, Baijal R, Amarapurkar D, Gupte P, Patel N, Kumar P, Agal S. Guillain-Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol. 2005;24(5):216.","journal-title":"Indian J Gastroenterol"},{"issue":"12","key":"2959_CR13","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/S0002-9270(00)02202-4","volume":"95","author":"A Sood","year":"2000","unstructured":"Sood A, Midha V, Sood N. Guillain-Barre syndrome with acute hepatitis E. Am J Gastroenterol. 2000;95(12):3667\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"2959_CR14","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3748\/wjg.15.1645","volume":"15","author":"JP Loly","year":"2009","unstructured":"Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J, Moonen G, Delwaide J. Guillain-Barre syndrome following hepatitis E. World J Gastroenterol. 2009;15(13):1645\u20137.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2959_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11845-010-0635-7","volume":"180","author":"S Cronin","year":"2011","unstructured":"Cronin S, McNicholas R, Kavanagh E, Reid V, O'Rourke K. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci. 2011;180(1):255\u20137.","journal-title":"Ir J Med Sci"},{"issue":"3","key":"2959_CR16","first-page":"389","volume":"4","author":"R Kumar","year":"2002","unstructured":"Kumar R, Bhoi S, Kumar M, Sharma B, Singh B, Gupta B. Guillain-Barr\u00e9 syndrome and acute hepatitis E: a rare association. JIACM. 2002;4(3):389\u201391.","journal-title":"JIACM"},{"issue":"3","key":"2959_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s15010-011-0185-6","volume":"40","author":"I Maurissen","year":"2012","unstructured":"Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection. 2012;40(3):323\u20136.","journal-title":"Infection"},{"issue":"10","key":"2959_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA van Doorn","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008;7(10):939\u201350.","journal-title":"Lancet Neurol"},{"issue":"2","key":"2959_CR19","first-page":"32","volume":"1","author":"RA Khanam","year":"2008","unstructured":"Khanam RA, Faruq MO, Basunia RA, Ahsan AA. Guillain-Barr\u00e9 syndrome associated with acute HEV hepatitis. Med Coll J. 2008;1(2):32\u20134.","journal-title":"Med Coll J"},{"issue":"5","key":"2959_CR20","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jhep.2012.05.010","volume":"57","author":"A Del Bello","year":"2012","unstructured":"Del Bello A, Arne-Bes MC, Lavayssiere L, Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol. 2012;57(5):1152\u20133.","journal-title":"J Hepatol"},{"issue":"4","key":"2959_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jocn.2011.06.024","volume":"19","author":"AC Tse","year":"2012","unstructured":"Tse AC, Cheung RT, Ho SL, Chan KH. Guillain-Barre syndrome associated with acute hepatitis E infection. J Clin Neurosci. 2012;19(4):607\u20138.","journal-title":"J Clin Neurosci"},{"issue":"34","key":"2959_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2807\/1560-7917.ES2013.18.34.20563","volume":"18","author":"L Santos","year":"2013","unstructured":"Santos L, Mesquita JR, Rocha PN, Lima-Alves C, Serrao R, Figueiredo P, Reis J, Simoes J, Nascimento M, Sarmento A. Acute hepatitis E complicated by Guillain-Barre syndrome in Portugal, December 2012--a case report. Euro Surveill. 2013;18(34):6\u20139.","journal-title":"Euro Surveill"},{"issue":"2","key":"2959_CR23","first-page":"186","volume":"19","author":"B Sharma","year":"2013","unstructured":"Sharma B, Nagpal K, Bakki SR, Prakash S. Hepatitis E with Gullain-Barre syndrome: still a rare association. J Neuro-Oncol. 2013;19(2):186\u20137.","journal-title":"J Neuro-Oncol"},{"issue":"9","key":"2959_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/cit512","volume":"57","author":"CH Geurtsvankessel","year":"2013","unstructured":"Geurtsvankessel CH, Islam Z, Mohammad QD, Jacobs BC, Endtz HP, Osterhaus AD. Hepatitis E and Guillain-Barre syndrome. Clin Infect Dis. 2013;57(9):1369\u201370.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2959_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","volume":"82","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, van der Eijk AA, Pas SD, Hunter JG, Madden RG, Tio-Gillen AP, Dalton HR, Jacobs BC. Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82(6):491\u20137.","journal-title":"Neurology"},{"issue":"9","key":"2959_CR26","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10072-014-1731-7","volume":"35","author":"XD Chen","year":"2014","unstructured":"Chen XD, Zhou YT, Zhou JJ, Wang YW, Tong DM. Guillain-Barre syndrome and encephalitis\/encephalopathy of a rare case of northern China acute severe hepatitis E infection. Neurol Sci. 2014;35(9):1461\u20133.","journal-title":"Neurol Sci"},{"issue":"1","key":"2959_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s15010-013-0448-5","volume":"42","author":"N Scharn","year":"2014","unstructured":"Scharn N, Ganzenmueller T, Wenzel JJ, Dengler R, Heim A, Wegner F. Guillain-Barre syndrome associated with autochthonous infection by hepatitis E virus subgenotype 3c. Infection. 2014;42(1):171\u20133.","journal-title":"Infection"},{"issue":"11\u201312","key":"2959_CR28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/apt.12986","volume":"40","author":"KL Woolson","year":"2014","unstructured":"Woolson KL, Forbes A, Vine L, Beynon L, McElhinney L, Panayi V, Hunter JG, Madden RG, Glasgow T, Kotecha A, et al. Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther. 2014;40(11\u201312):1282\u201391.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2959_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.revmed.2013.05.005","volume":"35","author":"T Comont","year":"2014","unstructured":"Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. Acute hepatitis E infection associated with Guillain-Barre syndrome in an immunocompetent patient. Rev Med Interne. 2014;35(5):333\u20136.","journal-title":"Rev Med Interne"},{"key":"2959_CR30","first-page":"759495","volume":"2015","author":"D Bandyopadhyay","year":"2015","unstructured":"Bandyopadhyay D, Ganesan V, Choudhury C, Kar SS, Karmakar P, Choudhary V, Banerjee P, Bhar D, Hajra A, Layek M, et al. Two uncommon causes of Guillain-Barre syndrome: hepatitis E and Japanese encephalitis. Case Rep Neurol Med. 2015;2015:759495.","journal-title":"Case Rep Neurol Med"},{"issue":"12","key":"2959_CR31","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2169\/internalmedicine.54.3506","volume":"54","author":"MA Higuchi","year":"2015","unstructured":"Higuchi MA, Fukae J, Tsugawa J, Ouma S, Takahashi K, Mishiro S, Tsuboi Y. Dysgeusia in a patient with Guillain-Barre syndrome associated with acute hepatitis E: a case report and literature review. Intern Med. 2015;54(12):1543\u20136.","journal-title":"Intern Med"},{"issue":"11","key":"2959_CR32","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.3201\/eid2111.141789","volume":"21","author":"HB Perrin","year":"2015","unstructured":"Perrin HB, Cintas P, Abravanel F, Gerolami R, D'Alteroche L, Raynal JN, Alric L, Dupuis E, Prudhomme L, Vaucher E, et al. Neurologic disorders in Immunocompetent patients with autochthonous acute hepatitis E. Emerg Infect Dis. 2015;21(11):1928\u201334.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"2959_CR33","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","volume":"37","author":"J Fukae","year":"2016","unstructured":"Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y. Guillain-Barre and miller fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan. Neurol Sci. 2016;37(11):1849\u201351.","journal-title":"Neurol Sci"},{"issue":"3","key":"2959_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3350\/cmh.2015.0039","volume":"22","author":"SB Ji","year":"2016","unstructured":"Ji SB, Lee SS, Jung HC, Kim HJ, Kim HJ, Kim TH, Jung WT, Lee OJ, Song DH. A Korean patient with Guillain-Barre syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy. Clin Mol Hepatol. 2016;22(3):396\u20139.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"2959_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jmv.24620","volume":"89","author":"JH Lei","year":"2017","unstructured":"Lei JH, Tian Y, Luo HY, Chen Z, Peng F. Guillain-Barre syndrome following acute co-super-infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier. J Med Virol. 2017;89(2):368\u201372.","journal-title":"J Med Virol"},{"issue":"1","key":"2959_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/jamaneurol.2016.3541","volume":"74","author":"O Stevens","year":"2017","unstructured":"Stevens O, Claeys KG, Poesen K, Saegeman V, Van Damme P. Diagnostic challenges and clinical characteristics of hepatitis E virus-associated Guillain-Barre syndrome. Jama Neurol. 2017;74(1):26\u201333.","journal-title":"Jama Neurol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-2959-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T20:43:22Z","timestamp":1660337002000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-2959-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2959"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-2959-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this investigation was obtained from the Research Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, and the reference number was 2017658.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}